Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacific Biosciences of California Inc (NASDAQ:PACB)

3.33
Delayed Data
As of Jul 26
 +0.10 / +3.10%
Today’s Change
3.08
Today|||52-Week Range
9.50
-12.37%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$351.9M

Company Description

Pacific Biosciences of California, Inc. engages in the research, development and manufacture of sequencing systems for genetic analysis. It operates through the following geographical segments: North America, Europe, and Asia. It offers deoxyribonucleic acid sequencing, third generation sequencing instrument, compatible workflow and analysis, resequencing and variant detection, epigenetics, multiplexing, sample and template preparation kits, binding kits, and sequel software applications. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Contact Information

Pacific Biosciences of California, Inc.
1305 O'Brien Drive
Menlo Park California 94025
P:(650) 521-8000
Investor Relations:
(650) 521-8450

Employees

Shareholders

Other institutional28.57%
Mutual fund holders26.64%
Individual stakeholders13.44%

Top Executives

Michael W. HunkapillerExecutive Chairman, President & CEO
Susan K. BarnesCFO, Principal Accounting Officer & Executive VP
Stephen W. TurnerChief Technical Officer & Vice President
Jonas KorlachChief Scientific Officer
James Michael PhillipsSenior Vice President-Research & Development